Management of risk in peripheral artery disease: Recent therapeutic advances

This publication has 43 references indexed in Scilit:

• Clopidogrel versus aspirin for secondary prophylaxis of vascular events: a cost-effectiveness analysis
  The American Journal of Medicine, 2004
• Impact of ramipril in patients with evidence of clinical or subclinical peripheral arterial disease
  European Heart Journal, 2004
• High prevalence of peripheral arterial disease and co-morbidity in 6880 primary care patients: cross-sectional study
  Atherosclerosis, 2004
• Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients
  BMJ, 2002
• Peripheral Arterial Disease Detection, Awareness, and Treatment in Primary Care
  JAMA, 2001
• Antiplatelet Therapy and Other Interventions after Revascularisation Procedures in Patients with Peripheral Arterial Disease: a Meta-analysis
  European Journal of Vascular and Endovascular Surgery, 2000
• Incidence, Natural History and Cardiovascular Events in Symptomatic and Asymptomatic Peripheral Arterial Disease in the General Population
  International Journal of Epidemiology, 1996
• A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE)
  The Lancet, 1996
• Mortality over a Period of 10 Years in Patients with Peripheral Arterial Disease
  New England Journal of Medicine, 1992
• Edinburgh Artery Study: Prevalence of Asymptomatic and Symptomatic Peripheral Arterial Disease in the General Population
  International Journal of Epidemiology, 1991